SCHEMBL6737485

SCHEMBL6737485

CCCCC1OC(=O)c2cc(NC3CCCC3)ccc21

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAOB P27338 16/20 0.52
MAOA P21397 7/20 0.52
ABCB1 P08183 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6742467 0.99 MAOB (0.51) MAOBMAOAABCB1
SCHEMBL6739287 0.81 MAOB (0.55) MAOBMAOAABCB1
SCHEMBL28052055 0.81 MAOB (0.54) MAOBMAOAABCB1
SCHEMBL7100173 0.79 MAOB (0.52) MAOBMAOAABCB1
SCHEMBL6741234 0.79 MAOB (0.52) MAOBMAOAABCB1
SCHEMBL6742472 0.78 ABCB1 (0.58) MAOBMAOAABCB1
SCHEMBL6737479 0.77 ABCB1 (0.60) MAOBMAOAABCB1
SCHEMBL6737859 0.76 ABCB1 (0.56) MAOBMAOAABCB1
SCHEMBL6739520 0.76 ABCB1 (0.56) MAOBMAOAABCB1
SCHEMBL6744484 0.76 ABCB1 (0.54) MAOBMAOAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689808-B2 TREATING OR PREVENTING EPILEPSY OR NEURODEGENERATIVE DISEASES LES LABORATOIRES SERVIER (FR) 2004-02-10 US disclosed
US-20030220393-A1 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2003-11-27 US disclosed
EP-1320528-A2 SUBSTITUTED PHTHALIDES AS ANTI-CONVULSIVE DRUGS THE INSTITUTE OF MATERIA MEDICA OF CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2003-06-25 EP disclosed
WO-2002000638-A2 SUBSTITUTED PHTHALIDES AS ANTI-CONVULSIVE DRUGS INSTITUTE OF MATERIA MEDICA (CN) 2002-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220393-A1 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them NR5A2, NR2E3, NR4A1 MAOB 1112/4885MAOA 572/4885ABCB1 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.